Leica Biosystems announced that it has acquired Kreatech Diagnostics, a privately-held provider of DNA flourescent in-situ hybridization (FISH) probes and target labeling reagents for microarrays.
Leica Biosystems announced that it has acquired Kreatech Diagnostics, a privately-held provider of DNA flourescent in-situ hybridization (FISH) probes and target labeling reagents for microarrays.
Ready to take your business to the next level? Our team of experts are here to provide the strategic advice and tailored solutions you need to excel.